tiprankstipranks
Aptose Biosciences (TSE:APS)
TSX:APS
Canadian Market
APS
Aptose Biosciences
RESEARCH TOOLSreports

Aptose Biosciences (APS) Financial Statements

145 Followers

Aptose Biosciences Financial Overview

Aptose Biosciences's market cap is currently C$6.05M. The company's EPS TTM is C$-4.193974803; its P/E ratio is -0.13; Aptose Biosciences is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -425.32K$ 0.00$ -474.55K$ -507.08K$ -616.53K
Operating Income$ -25.16M$ -26.26M$ -52.36M$ -42.60M$ -65.45M
EBITDA$ -24.73M$ -26.23M$ -52.27M$ -42.48M$ -65.30M
Net Income$ -25.91M$ -25.43M$ -51.21M$ -41.82M$ -65.35M
Balance Sheet
Cash & Short-Term Investments$ 4.09M$ 6.15M$ 9.25M$ 46.96M$ 79.13M
Total Assets$ 9.99M$ 10.13M$ 12.99M$ 51.03M$ 82.53M
Total Debt$ 28.01M$ 10.64M$ 1.01M$ 1.30M$ 574.00K
Net Debt$ 23.93M$ -5.53M$ -8.24M$ -35.67M$ -38.54M
Total Liabilities$ 37.11M$ 14.67M$ 15.89M$ 13.29M$ 8.29M
Stockholders' Equity$ -27.12M$ -4.54M$ -2.90M$ 37.74M$ 74.24M
Cash Flow
Free Cash Flow$ -22.37M$ -35.98M$ -44.62M$ -32.35M$ -43.52M
Operating Cash Flow$ -22.37M$ -35.98M$ -44.59M$ -32.32M$ -43.30M
Investing Cash Flow$ 0.00$ 18.00K$ 9.96M$ 30.07M$ -35.21M
Financing Cash Flow$ 19.72M$ 33.41M$ 6.91M$ 116.00K$ 226.00K
Currency in USD

Aptose Biosciences Earnings and Revenue History

Income Statement >

Aptose Biosciences Debt to Assets

Balance Sheet >

Aptose Biosciences Cash Flow

Cash Flow >

Aptose Biosciences Forecast EPS vs Actual EPS

Earnings >